← Leaderboards
Mark Daniel Unger
Interventional Analgesix, Inc.
$109,354
Attributed
$218,707
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$218,707 · 1
By mechanism
R43$218,707 · 1
Top collaborators
- Andreas S Beutler1 shared
Others in their field
Other Emerging Leaders on “Absence Of Pain Sensation”
- Jeffrey Reich · Sparian Biosciences, Inc.$21,990,518
- John Cureton Hunter · Siteone Therapeutics, Inc.$5,359,866
- Donald R Gehlert · Epiodyne, Inc.$5,302,597
- William K Schmidt · Epiodyne, Inc.$5,302,597
- James E. Barrett · Mebias Discovery, Inc.$4,805,544
- Lawrence C Kuo · Mebias Discovery, Inc.$4,805,544
Research focus
Absence Of Pain SensationAffectAgonistAmericanAnalgesicsAnaphylaxisAnimal ModelAnimalsBusinessesCapitalCationsCerebrospinal FluidChemistryChronicChronic PainChronic Pain ReliefClinical DevelopmentClinical ProtocolsCohortConventional TherapyCyclodextrinsDetectionDifferential Scanning CalorimetryAblation